Advanced search
Publication Cover
International Journal of Chronic Obstructive Pulmonary Disease Volume 16, 2021 - Issue
Submit an article Journal homepage
116
Views
10
CrossRef citations to date
0
Altmetric
Original Research

Exploring PI3Kδ Molecular Pathways in Stable COPD and Following an Acute Exacerbation, Two Randomized Controlled Trials

Malcolm Begg1 Refractory Respiratory Inflammation Discovery Performance Unit, GlaxoSmithKline, Stevenage, UKCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-9508-3424View further author information
ORCID Icon,
J Nicole Hamblin1 Refractory Respiratory Inflammation Discovery Performance Unit, GlaxoSmithKline, Stevenage, UKView further author information
,
Emily Jarvis2 Biostatistics, GlaxoSmithKline R&D, Stevenage, UKORCID Iconhttps://orcid.org/0000-0001-7187-6382View further author information
ORCID Icon,
Glyn Bradley3 Computational Biology, Medicinal Science and Technology, GlaxoSmithKline, Stevenage, UKView further author information
,
Stephen Mark4 Study Management, Clinical Development, GlaxoSmithKline, Mississauga, ON, CanadaView further author information
,
David Michalovich5 Adaptive Immunity Research Unit, GlaxoSmithKline, Stevenage, UKView further author information
,
Mark Lennon6 Nonclinical and Translational Statistics, GlaxoSmithKline, Stevenage, UKView further author information
,
Hannah E Wajdner5 Adaptive Immunity Research Unit, GlaxoSmithKline, Stevenage, UKView further author information
,
Augustin Amour5 Adaptive Immunity Research Unit, GlaxoSmithKline, Stevenage, UKView further author information
,
Robert Wilson1 Refractory Respiratory Inflammation Discovery Performance Unit, GlaxoSmithKline, Stevenage, UKView further author information
,
Ken Saunders5 Adaptive Immunity Research Unit, GlaxoSmithKline, Stevenage, UKView further author information
,
Rikako Tanaka7 Data Management & Strategy, Clinical Development, GlaxoSmithKline, Tokyo, JapanView further author information
,
Saki Arai7 Data Management & Strategy, Clinical Development, GlaxoSmithKline, Tokyo, JapanView further author information
,
Teresa Tang8 Pharma Safety, Clinical Development, GlaxoSmithKline, Brentford, Middlesex, UKView further author information
,
Cedric Van Holsbeke9 FLUIDDA nv, Kontich, 2550, BelgiumORCID Iconhttps://orcid.org/0000-0003-0248-841XView further author information
ORCID Icon,
Jan De Backer9 FLUIDDA nv, Kontich, 2550, BelgiumView further author information
,
Wim Vos9 FLUIDDA nv, Kontich, 2550, BelgiumView further author information
,
Ingrid L Titlestad10 Department of Respiratory Medicine, Odense University Hospital and University of Southern Denmark, Odense, DenmarkORCID Iconhttps://orcid.org/0000-0001-6418-0088View further author information
ORCID Icon,
J Mark FitzGerald11 Centre for Heart and Lung Health, University of British Columbia, Vancouver, BC, CanadaView further author information
,
Kieran Killian12 Cardiorespiratory Research Laboratory, Faculty of Health Sciences, McMaster University, Hamilton, ON, CanadaView further author information
,
Jean Bourbeau13 Department of Medicine, Division of Experimental Medicine, McGill University, Montreal, QC, CanadaView further author information
,
Claude Poirier14 Department of Medicine, Respiratory Medicine Division, University of Montreal, Montreal, QC, CanadaView further author information
,
François Maltais15 Institut Universitaire de Cardiologie et de Pneumologie de Québe, Université Laval, Quebec City, QC, CanadaORCID Iconhttps://orcid.org/0000-0002-6809-4651View further author information
ORCID Icon,
Anthony Cahn1 Refractory Respiratory Inflammation Discovery Performance Unit, GlaxoSmithKline, Stevenage, UKView further author information
&
Edith M Hessel1 Refractory Respiratory Inflammation Discovery Performance Unit, GlaxoSmithKline, Stevenage, UKORCID Iconhttps://orcid.org/0000-0002-2339-4482View further author information
ORCID Icon show all
Pages 1621-1636 | Published online: 03 Jun 2021

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.